Cancer. Elevated cancer antigen 125 [CA 125]
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Definite diagnosis of cancer by an oncologist Completed at least one course of chemotherapy with antiemetic chemotherapy drugs including cyclophosphamide, cisplatin, carboplatin and doxorubicin in a single or multiple regimen No history of nausea and vomiting for reasons other than chemotherapy No digestive problems or diarrhea Age over 18 Not pregnant or breastfeeding Not taking sedatives and antidepressants
Exclusion criteria
Exclusion criteria: Lack of study inclusion criteria Unwillingness to participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Chemotherapy-induced nausea and vomiting score on the MAT questionnaire. Timepoint: In 3 cycles of chemotherapy, 2 times per cycle (in the first 24 hours and after the first 24 hours after chemotherapy). Method of measurement: Multinational Association of Supportive Care in Cancer Antiemesis Tool. | — |
Countries
Iran (Islamic Republic of)
Contacts
Yasouj University of Medical Sciences